These signalling pathways are amenable to morphologic study of tumour specimens by β-catenin or SMAD4 immunohistochemistry, respectively: as downstream-effectors in the signalling cascades, when activated, these proteins can be found in the nuclei of the tumour cells [4, 5]. This evidence concerns the gene SMAD4 and neoplasm.